Investigator Sponsored Trials

Investigator Sponsored Trials

Program Description

Our Investigator-Sponsored Trials (IST) program provides support for external clinical research that advances medical and/or scientific knowledge about our products, with the goal of enhancing patient care. Our current IST program supports hematology/oncology indications and will consider protocols based on a strong scientific rationale.

The objective of our IST program is to provide funding and/or study drug for clinical research that will address unmet medical needs with new scientific data and support pilot studies that explore the feasibility of new treatments.

Potential Areas of Interest

  • New combination therapies
  • Earlier line of treatment
  • New/different doses and schedules of panobinostat
  • Combination therapies
  • Post-transplant
  • Combination therapies

Submit a Proposal

To submit a proposal to Secura Bio, complete the online form and email it to
IST@securabio.com.

For questions related to form submission, please email IST@securabio.com.